{"id":"https://openalex.org/W2006024908","doi":"https://doi.org/10.1016/s0009-9236(02)17636-3","title":"Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil","display_name":"Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil","alternate_titles":[],"publication_year":2003,"publication_date":"2003-04-01","ids":{"openalex":"https://openalex.org/W2006024908","doi":"https://doi.org/10.1016/s0009-9236(02)17636-3","mag":"2006024908","pmid":"https://pubmed.ncbi.nlm.nih.gov/12709724"},"language":"en","primary_location":{"id":"doi:10.1016/s0009-9236(02)17636-3","doi":"https://doi.org/10.1016/s0009-9236(02)17636-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(02)17636-3","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2006024908"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002808291","display_name":"Eric P. Brass","orcid":"https://orcid.org/0009-0009-6260-2414","observed_orcids":["https://orcid.org/0009-0009-6260-2414"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210110978","display_name":"Louis Stokes Cleveland VA Medical Center","ror":"https://ror.org/01vrybr67","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210110978","https://openalex.org/I4210127612"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"E Brass","raw_affiliation_strings":["Harbor-UCLA Center for Clinical Pharmacology, Torrance, CA 90502. ebrass@ucla.edu","Harbor\u2010UCLA Center for Clinical Pharmacology, Torrance TAP Pharmaceutical Products, Inc Lake Forest","Louis Stokes Veterans Administration Hospital and Case Western Reserve University, Cleveland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harbor-UCLA Center for Clinical Pharmacology, Torrance, CA 90502. ebrass@ucla.edu","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Harbor\u2010UCLA Center for Clinical Pharmacology, Torrance TAP Pharmaceutical Products, Inc Lake Forest","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Louis Stokes Veterans Administration Hospital and Case Western Reserve University, Cleveland","institution_ids":["https://openalex.org/I4210110978","https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael D Mayer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael D Mayer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059897060","display_name":"Darcy J. Mulford","orcid":"https://orcid.org/0009-0001-7702-5420","observed_orcids":["https://orcid.org/0009-0001-7702-5420"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Darcy J Mulford","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161634075","display_name":"Therese K Stickler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Therese K Stickler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5063050485","display_name":"Charles L. Hoppel","orcid":"https://orcid.org/0000-0001-9755-8091","observed_orcids":["https://orcid.org/0000-0001-9755-8091"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charles L Hoppel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5002808291"],"corresponding_institution_ids":["https://openalex.org/I161318765","https://openalex.org/I4210110978","https://openalex.org/I58956616"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":2.1527,"has_fulltext":false,"cited_by_count":53,"citation_normalized_percentile":{"value":0.85000599,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"73","issue":"4","first_page":"338","last_page":"347"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.4458000063896179,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.4458000063896179,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11027","display_name":"Metabolism and Genetic Disorders","score":0.1454000025987625,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.08060000091791153,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cefditoren-pivoxil","display_name":"cefditoren pivoxil","score":0.9990000128746033},{"id":"https://openalex.org/keywords/carnitine-homeostasis","display_name":"carnitine homeostasis","score":0.9440000057220459},{"id":"https://openalex.org/keywords/urinary-carnitine-excretion","display_name":"urinary carnitine excretion","score":0.9480000138282776},{"id":"https://openalex.org/keywords/acetyl-l-carnitine","display_name":"acetyl-L-carnitine","score":0.9559999704360962},{"id":"https://openalex.org/keywords/plasma-carnitine","display_name":"plasma carnitine","score":0.7590000033378601},{"id":"https://openalex.org/keywords/dose-dependent-effects","display_name":"dose-dependent effects","score":0.6650000214576721},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.7459999918937683},{"id":"https://openalex.org/keywords/cephalosporin-adverse-effects","display_name":"cephalosporin adverse effects","score":0.8180000185966492}],"concepts":[{"id":"https://openalex.org/C2778435403","wikidata":"https://www.wikidata.org/wiki/Q243309","display_name":"Carnitine","level":2,"score":0.8070613145828247},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.6516687870025635},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5557295680046082},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5440387725830078},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4600616991519928},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.41671067476272583},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3503721356391907},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3459465503692627}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002331","descriptor_name":"Carnitine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002331","descriptor_name":"Carnitine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002331","descriptor_name":"Carnitine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006706","descriptor_name":"Homeostasis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008401","descriptor_name":"Gas Chromatography-Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0009-9236(02)17636-3","doi":"https://doi.org/10.1016/s0009-9236(02)17636-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(02)17636-3","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:12709724","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12709724","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1242977","https://openalex.org/W202961515","https://openalex.org/W1487827437","https://openalex.org/W1598161624","https://openalex.org/W1775915449","https://openalex.org/W1871553184","https://openalex.org/W1897155209","https://openalex.org/W1939106888","https://openalex.org/W1990531193","https://openalex.org/W1994931868","https://openalex.org/W2005883651","https://openalex.org/W2010976466","https://openalex.org/W2011199378","https://openalex.org/W2022313595","https://openalex.org/W2034890458","https://openalex.org/W2040950841","https://openalex.org/W2051360601","https://openalex.org/W2051542544","https://openalex.org/W2051920392","https://openalex.org/W2063303266","https://openalex.org/W2067449320","https://openalex.org/W2075974697","https://openalex.org/W2088791781","https://openalex.org/W2092389641","https://openalex.org/W2095371633","https://openalex.org/W2099566887","https://openalex.org/W2102083512","https://openalex.org/W2102293583","https://openalex.org/W2109192859","https://openalex.org/W2116709741","https://openalex.org/W2119675339","https://openalex.org/W2170085053","https://openalex.org/W2340271094","https://openalex.org/W2398018522","https://openalex.org/W2414118414","https://openalex.org/W3191020659"],"related_works":["https://openalex.org/W2110591952","https://openalex.org/W358123161","https://openalex.org/W2143374279","https://openalex.org/W2084846418","https://openalex.org/W2002594435","https://openalex.org/W2022313595","https://openalex.org/W2034104013","https://openalex.org/W1996144936","https://openalex.org/W2083599435","https://openalex.org/W2040950841"],"abstract_inverted_index":{"BACKGROUND:":[0],"Pivalate-generating":[1],"prodrugs":[2],"have":[3],"been":[4],"suggested":[5],"to":[6,29,65,119,133,182,242],"cause":[7],"clinically":[8],"significant":[9],"hypocarnitinemia.":[10],"To":[11],"evaluate":[12],"the":[13,106,176,186,192,229],"effect":[14],"of":[15,44,68,75,108,144,152,168,171,195,201,211,224,235],"pivalate":[16,25],"prodrug":[17],"treatment":[18],"on":[19,105],"carnitine":[20,34,81,91,101,161,170,219],"homeostasis,":[21],"we":[22],"administered":[23,41],"a":[24,156],"prodrug,":[26],"cefditoren":[27,50,59,95,109,147,202],"pivoxil,":[28],"healthy":[30],"subjects":[31],"and":[32,72,79,86,110,127,180,207],"performed":[33],"balance":[35],"studies.":[36],"METHODS:":[37],"Cefditoren":[38],"pivoxil":[39,96,203],"was":[40,103,191],"in":[42,100,124,138,155,159,205,244],"one":[43],"two":[45],"dosing":[46],"regimens":[47],"(200":[48],"mg":[49,58,146],"twice":[51,60,148],"daily":[52,61],"for":[53,62],"10":[54],"days":[55,143],"or":[56],"400":[57,145],"14":[63,142],"days)":[64],"gender-balanced":[66],"groups":[67],"15":[69],"subjects.":[70],"Plasma":[71,90],"urine":[73],"concentrations":[74,92],"carnitine,":[76],"acetylcarnitine,":[77],"pivaloylcarnitine,":[78],"total":[80,160,169,212],"were":[82,221],"quantified":[83],"before,":[84],"during,":[85],"after":[87,141],"treatment.":[88],"RESULTS:":[89],"fell":[93],"during":[94],"dosing.":[97],"The":[98],"nadir":[99],"concentration":[102],"dependent":[104],"dose":[107,231],"subject":[111],"gender":[112],"(decrease":[113],"from":[114,128],"44.8":[115],"+/-":[116,121,130,135],"10.9":[117],"micromol/L":[118,123,132,137],"9.2":[120],"1.9":[122],"male":[125],"patients":[126,140],"32.5":[129],"5.4":[131],"6.3":[134],"1.7":[136],"female":[139],"daily).":[149],"Urinary":[150],"elimination":[151],"pivaloylcarnitine":[153],"resulted":[154],"marked":[157],"increase":[158],"excretion,":[162],"as":[163,165],"well":[164],"net":[166,209,218],"losses":[167,210,220],"approximately":[172],"4.6":[173],"mmol":[174,184],"with":[175,185,228],"200-mg,":[177],"10-day":[178],"regimen":[179,232],"up":[181],"14.9":[183],"400-mg,":[187],"14-day":[188],"regimen.":[189],"Pivaloylcarnitine":[190],"dominant":[193],"form":[194],"excreted":[196],"pivalate.":[197],"DISCUSSION:":[198],"Short-term":[199],"administration":[200],"results":[204],"hypocarnitinemia":[206],"increased":[208],"carnitine.":[213],"It":[214],"is":[215],"estimated":[216],"that":[217],"only":[222],"10%":[223],"body":[225],"stores,":[226],"even":[227],"highest":[230],"tested.":[233],"Losses":[234],"this":[236],"magnitude":[237],"would":[238],"not":[239],"be":[240],"anticipated":[241],"result":[243],"adverse":[245],"clinical":[246],"effects.":[247]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2006024908","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
